Neurocrine Biosciences (NBIX) P/S US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/S | ? | 12.5 | 8.53 | 7.11 | 7.69 | 6.82 | 5.11 | ||
Changes by years, y/y, % | -12% | -32% | -17% | +8% | -11% | -13.7% |
Neurocrine Biosciences. P/S
Neurocrine Biosciences. P/S, changes, %
Neurocrine Biosciences (NBIX) P/S US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/S | ? | 6.17 | 6.87 | 6.94 | 6.55 | 5.19 | 5.11 | |
Changes by years, y/y, % | -16% | -11% | +13% | +19% | -16% | |||
Changes by quarters, q/q, % | +12% | +11% | +1% | -6% | -21% |